viral
quasispeci
may
possess
molecular
memori
past
evolutionari
histori
imprint
minor
compon
mutant
spectrum
report
experiment
evid
theoret
model
memori
retrovir
quasispeci
vivo
apart
replic
memori
associ
quasispeci
dynam
retrovirus
may
harbour
cellular
anatom
memori
deriv
integr
cycl
presenc
viral
reservoir
bodi
compart
three
independ
set
data
exemplifi
two
kind
memori
human
immunodefici
viru
type
data
provid
evid
reemerg
sequenc
hidden
cellular
anatom
compart
extend
period
infect
recoveri
quasispeci
preexist
genom
develop
threecompon
model
incorpor
essenti
featur
quasispeci
dynam
retrovirus
expos
select
pressur
significantli
numer
studi
base
model
agreement
experiment
data
support
exist
replic
reservoir
memori
retrovir
quasispeci
rna
virus
replic
complex
distribut
mutant
genom
term
viral
quasispeci
quasispeci
develop
gener
theori
understand
dynam
first
replic
molecul
context
origin
inform
earli
evolut
life
quasispeci
dynam
character
continu
process
mutant
gener
competit
select
also
provid
interpret
great
adapt
potenti
pathogen
rna
virus
evidenc
need
use
combin
antivir
therapi
design
polyval
antivir
vaccin
control
viral
diseas
review
domingo
et
al
understand
quasispeci
dynam
open
new
antivir
strategi
viru
entri
error
catastroph
also
term
lethal
mutagenesi
review
eigen
experi
anim
pathogen
footandmouth
diseas
viru
fmdv
document
rna
viru
quasispeci
may
possess
genet
memori
genom
domin
earlier
phase
evolut
memori
detect
minor
genom
replic
mutant
spectrum
two
independ
evolutionari
lineag
fmdv
cell
cultur
presenc
replic
memori
genom
viral
quasispeci
may
repres
select
advantag
viru
whenev
fluctuat
select
pressur
occur
exampl
prolong
chronic
infect
howev
direct
evid
quasispeci
memori
vivo
present
far
human
retrovir
pathogen
whose
popul
particip
quasispeci
dynam
review
crandal
includ
two
dispar
phase
replic
cycl
integr
provirus
cdna
copi
rna
replic
cellular
gene
high
fidel
copi
inher
cellular
dna
polymeras
endow
proofreadingrepair
activ
subject
also
postrepl
repair
pathway
upon
express
integr
site
viral
rna
process
direct
synthesi
multipl
protein
culmin
format
retrovir
particl
whose
first
replic
step
upon
enter
new
host
cell
errorpron
copi
genom
rna
dna
retrovir
revers
transcriptas
rt
replic
cycl
favour
exist
second
type
genet
memori
differ
replic
memori
describ
fmdv
picornaviru
whose
rna
replic
cycl
includ
dna
step
integr
dna
copi
genom
constitut
reservoir
viral
sequenc
upon
cellular
activ
contribut
new
mutant
distribut
replic
pool
viru
sever
anatom
compart
includ
lymph
node
cell
type
rest
lymphocyt
macrophag
other
potenti
reservoir
virus
reservoir
evolv
slowli
circul
plasma
patient
maintain
month
year
genotyp
exhibit
enter
reservoir
genotyp
either
wildtyp
drugresist
independ
genotyp
current
domin
plasma
integr
provirus
affect
select
pressur
revers
transcriptas
inhibitor
rti
whilst
express
follow
activ
host
lymphocyt
may
sensit
proteas
inhibitor
pri
also
anatom
site
may
provid
barrier
antiretrovir
pressur
due
limit
access
drug
ie
pri
virus
reservoir
could
reemerg
occupi
circul
quasispeci
document
phylogenet
analys
consensu
sequenc
reemerg
could
consequ
structur
treatment
interrupt
figur
show
flux
diagram
infect
take
account
differ
cellular
type
contribut
repres
sourc
memori
circul
quasispeci
quantit
data
provid
direct
experiment
evid
occurr
memori
quasispeci
present
mathemat
model
distinguish
replic
memori
transient
nonrepl
reservoir
memori
oper
discuss
implic
two
type
memori
retroviru
adapt
reemerg
sequenc
prolong
time
infect
nonrepl
reservoir
memori
investig
exist
put
sourc
memori
quasispeci
three
patient
refer
case
case
case
detail
materi
method
select
due
poor
respons
therapi
andor
fluctuat
observ
viral
load
lymphocyt
count
complex
treatment
histori
tabl
possibl
contribut
nonrepl
reservoir
memori
studi
mean
sequenc
analysi
retrospect
viral
sampl
two
patient
case
consensu
nucleotid
sequenc
use
deduc
amino
acid
substitut
present
codon
proteas
pr
first
codon
rt
tabl
sequenti
sequenc
case
show
progress
accumul
resist
mutat
five
year
exposur
azt
monotherapi
april
decemb
combin
ddi
may
accumul
nucleosideresist
mutat
tabl
led
select
multinucleosideresist
genom
encod
insert
sampl
shift
haart
combin
rtv
result
absenc
insertcontain
genotyp
sampl
collect
two
month
later
interestingli
sampl
follow
one
exhibit
mutat
pattern
rt
close
first
avail
sampl
patient
provir
dna
collect
august
conserv
mutat
found
rtcode
region
prior
may
reemerg
initi
genotyp
evid
consensu
sequenc
prcode
region
although
shift
consensu
sequenc
lack
key
substitut
observ
sampl
tabl
differ
behaviour
rt
pr
gene
could
due
absenc
select
pressur
act
pr
result
independ
evolut
intrapati
recombin
event
differ
phylogenet
approach
use
analys
consecut
consensu
sequenc
order
evalu
possibl
reemerg
virus
could
hidden
cellular
anatom
compart
novemb
juli
nj
upgma
mp
ml
method
produc
overal
tree
topolog
consensu
sequenc
pol
env
region
figur
b
phylogenet
relationship
highli
consist
show
clear
separ
two
group
isol
genom
progress
accumul
nucleosid
analogresist
mutat
provir
sequenc
ancestr
genom
present
reemerg
case
patient
poor
adher
treatment
show
larg
fluctuat
viral
load
respons
differ
haart
regim
period
studi
tabl
interrupt
regim
compos
ddi
rtv
sqv
septemb
larg
fluctuat
viral
load
mutat
pattern
record
consensu
sequenc
octob
septemb
tabl
amino
acid
substitut
pr
rt
suggest
occurr
two
progress
reemerg
event
sampl
would
result
reemerg
virus
relat
sampl
definitori
amino
acid
replac
pr
rt
sampl
would
result
reemerg
sequenc
sampl
signatur
substitut
pr
rt
amino
acid
replac
relat
drug
resist
pri
rti
phylogenet
analysi
sequenti
consensu
sequenc
use
mp
nj
upgma
ml
indic
isomorph
topolog
pol
env
case
figur
apart
nonrepl
memori
due
reemerg
cellular
anatom
compart
replic
memori
could
also
exist
retrovirus
analog
previous
document
fmdv
evalu
possibl
presenc
replic
memori
detail
phylogenet
analysi
perform
sequenti
clonal
sequenc
case
patient
key
mutat
relat
decreas
sensit
inhibitor
maintain
time
point
yet
domin
genom
encod
rt
insert
lost
within
six
month
interv
januari
june
probabl
result
switch
azt
ddc
treatment
ddi
monotherapi
reintroduct
azt
combin
associ
select
june
august
viru
whose
consensu
sequenc
contain
rt
insert
tabl
mp
analysi
bp
long
sequenc
molecular
clone
span
prcode
region
first
codon
rt
six
sequenti
sampl
tabl
use
refer
sequenc
show
separ
statist
support
bootstrap
resampl
sequenc
harbour
dipeptid
insert
either
serser
sergli
without
contribut
differ
infect
cell
circul
quasispeci
follow
circul
virion
produc
activ
replic
lymphocyt
constitut
total
number
lymphocyt
virion
come
macrophag
anoth
follicular
dendrit
cell
final
less
produc
upon
activ
latent
infect
lymphocyt
repres
total
number
lymphocyt
lymphocyt
infect
defect
virus
contribut
circul
quasispeci
three
type
lymphocyt
similarli
distribut
lymph
node
bloodstream
base
data
ref
refer
therein
rt
insert
figur
sampl
sampl
consensu
sequenc
rt
tabl
contain
one
clone
without
insert
cluster
clone
except
three
sampl
convers
sampl
consensu
sequenc
without
rt
insert
tabl
harbour
three
clone
genotyp
minor
sequenc
sampl
cluster
insertcontain
sequenc
sampl
therefor
minor
genom
without
insert
present
popul
domin
insertioncod
gen
sampl
identif
treatment
histori
clinic
event
patient
summar
tabl
singl
letter
amino
acid
aa
code
use
dash
mean
chang
rel
refer
sequenc
shown
top
strain
genbank
access
number
amino
acid
parenthesi
indic
residu
found
mixtur
amino
acid
refer
sequenc
shown
top
proport
rang
accord
sequenc
peak
pattern
data
case
adapt
brion
et
al
amino
acid
substitut
posit
relev
resist
pri
rti
highlight
boldfac
letter
b
current
therapi
sampl
date
indic
abbrevi
bc
bad
complianc
date
antiretrovir
therapi
introduct
drug
abbrevi
shown
tabl
ome
convers
minor
insertioncod
genom
present
popul
domin
virus
devoid
insert
result
suggest
presenc
replic
memori
quasispeci
result
sequenti
analys
figur
maximum
parsimoni
cluster
sequenc
molecular
clone
six
sequenti
sampl
case
use
refer
sequenc
uniqu
sequenc
identifi
sampleclon
number
see
tabl
group
clone
ident
sequenc
label
sampleletternumb
letter
consecut
group
one
sampl
number
indic
mani
ident
clone
belong
group
therefor
clone
repres
differ
sequenc
cluster
five
defect
clone
detect
sampl
group
colour
code
blue
sequenc
rt
insert
green
sequenc
rt
insert
red
sequenc
without
rt
insert
asterisk
indic
cluster
bootstrap
analysi
replica
gave
signific
higher
per
unit
minor
sequenc
sampl
underlin
sequenc
three
patient
tabl
figur
suggest
replic
memori
type
describ
previous
fmdv
togeth
nonrepl
reservoir
memori
oper
replic
vivo
order
describ
quantit
two
type
memori
made
use
mathemat
model
base
theori
quasispeci
involv
threecompon
system
although
detail
model
dynam
infect
consid
immun
respons
host
develop
focus
viral
quasispeci
dynam
regard
emerg
replic
nonrepl
memori
consid
popul
three
differ
viral
compon
j
denot
n
j
number
virus
compon
j
time
k
j
rate
reproduct
compon
j
virus
type
j
reproduc
constant
rate
given
k
j
offspr
per
parent
per
unit
time
introduc
qualiti
factor
q
j
j
fraction
faith
copi
j
rest
q
j
mutant
j
compon
k
constant
rate
mutat
j
k
term
kj
assum
kj
constant
kj
rang
differenti
equat
satisfi
n
j
assum
constant
popul
size
degrad
dn
j
dt
j
q
j
j
x
kj
jk
n
k
p
n
j
k
total
popul
size
p
k
j
n
j
rate
reproduct
qualiti
factor
mutat
rate
independ
quantiti
relat
ident
case
three
viral
speci
equal
k
n
k
n
k
n
n
n
n
case
two
speci
contribut
quasispeci
equat
slightli
differ
condit
impli
dn
dt
k
k
n
k
n
n
n
n
mn
dn
dt
k
k
n
k
n
n
n
n
mn
system
equat
written
compact
form
n
mn
dot
mean
time
deriv
introduc
matrix
interest
steadyst
quasispeci
solut
solut
provid
diagon
matrix
mean
find
diagon
matrix
l
nonsingular
matrix
l
omo
lo
quasispeci
made
n
differ
compon
late
time
limit
n
j
denot
n
j
given
assum
compon
quasispeci
fitter
rest
n
k
j
column
matrix
correspond
compon
eigenvector
therefor
comput
rel
fraction
given
equat
requir
largest
eigenvalu
l
correspond
eigenvector
rel
fraction
quasispeci
given
et
al
case
n
matrix
need
diagon
correspond
eigenvalu
equat
coeffici
given
solut
largest
eigenvalu
l
given
term
eigenvalu
rel
fraction
steadyst
quasispeci
given
numer
approach
allow
solv
system
differenti
equat
equat
case
n
equat
case
n
given
initi
intermedi
condit
start
time
viral
compon
present
arbitrari
initi
condit
n
n
respect
late
time
limit
depend
initi
condit
rate
reproduct
k
k
valu
k
rel
highest
one
alway
consid
k
time
time
let
system
evolv
assum
suffici
late
n
n
n
n
quasispeci
valu
correspond
choic
paramet
k
k
respect
evolut
character
n
n
later
time
system
expos
select
pressur
compon
affect
compon
affect
particular
case
dynam
vivo
select
pressur
identifi
antivir
treatment
sensit
treatment
wherea
resist
correspond
situat
k
k
short
period
select
pressur
withdrawn
expect
recov
k
k
k
larger
initi
k
valu
mean
compon
becom
fitter
new
valu
k
k
let
system
evolv
suffici
late
time
n
n
reach
new
quasispeci
valu
valu
constant
chang
particular
n
n
n
n
valu
n
correspond
level
molecular
replic
memori
compon
evolut
character
quasispeci
valu
later
time
appli
second
select
pressur
differ
antivir
treatment
favour
new
compon
move
reservoir
bloodstream
thu
circul
quasispeci
includ
three
compon
assum
compon
sensit
treatment
compon
resist
fitter
reason
compon
move
reservoir
compart
bloodstream
k
k
k
second
treatment
maintain
compon
remain
major
quasispeci
recogn
consensu
sequenc
correspond
situat
report
case
reemerg
ancestr
compon
genom
detect
consensu
sequenc
follow
long
domin
compon
genom
discontinu
second
treatment
time
system
recov
fit
ratio
k
k
k
later
time
suffici
system
reach
steadyst
obtain
new
quasispeci
valu
set
paramet
n
n
n
quasispeci
level
n
would
correspond
contribut
nonrepl
reservoir
compon
quasispeci
memori
run
three
numer
comput
correspond
three
differ
valu
mutat
rate
name
figur
depict
one
exampl
time
evolut
system
therefor
theoret
treatment
quasispeci
dynam
permit
model
two
type
memori
replic
agreement
experiment
analys
genom
evolut
patient
undergo
antiretrovir
therapi
presenc
memori
genom
viral
quasispeci
document
design
experi
employ
fmdv
expect
consequ
quasispeci
dynam
retrovirus
level
complex
replic
quasispeci
one
time
expect
greater
nonretrovir
ribovirus
provir
sequenc
maintain
minim
occur
point
mutat
associ
cellular
gene
activ
perturb
dynam
replic
retrovir
particl
evid
reemerg
ancestr
viral
sequenc
previous
obtain
phylogenet
method
extens
appli
molecular
epidemiolog
virus
includ
origin
hiv
spread
differ
geograph
area
impact
viral
mutat
recombin
host
interact
popul
dynam
present
studi
use
procedur
provid
evid
presenc
memori
quasispeci
three
patient
subject
success
well
defin
select
antivir
pressur
case
document
reemerg
viral
genom
could
hidden
cellular
anatom
bodi
compart
month
memori
virus
lack
nucleosid
resist
mutat
includ
insert
progress
accumul
circul
quasispeci
introduct
potent
haart
regim
tc
rtv
would
elimin
circul
virus
ancestr
probabl
fitter
virus
would
move
reservoir
bloodstream
previou
clonal
analysi
provid
evid
minor
member
replic
quasispeci
surviv
treatment
although
minor
could
detect
level
analysi
case
reveal
reemerg
viral
genom
occur
two
consecut
round
result
treatment
interrupt
incomplet
adher
case
mp
analysi
molecular
clone
indic
minor
genom
without
rt
insert
sampl
total
quasispeci
becam
major
sampl
probabl
due
left
axi
correspond
n
green
line
right
axi
correspond
n
blue
line
n
pink
line
notic
differ
scale
left
right
axe
valu
right
axi
decreas
power
time
decreas
power
simul
shown
paramet
chosen
simul
follow
time
n
n
k
k
time
system
reach
steadyst
correspond
valu
k
j
time
twocompon
system
expos
select
pressur
antivir
treatment
k
k
time
select
pressur
switch
k
k
time
system
reach
steadyst
correspond
valu
k
j
valu
n
correspond
level
replic
memori
compon
level
exampl
time
system
expos
second
select
pressur
differ
antivir
treatment
forc
new
compon
move
reservoir
bloodstream
initi
condit
compon
chosen
n
n
k
k
k
time
select
pressur
switch
k
k
k
time
system
reach
steadyst
correspond
valu
k
j
valu
n
reflect
contribut
nonrepl
reservoir
compon
quasispeci
memori
level
simul
higher
fit
six
month
absenc
azt
ddc
therapi
presenc
ddi
minor
genom
maintain
genotyp
sampl
total
quasispeci
like
select
reintroduct
azt
togeth
restor
quasispeci
domin
virus
rt
insert
sampl
collect
two
month
sampl
tabl
insert
rt
probabl
maintain
rest
infect
due
multinucleosid
resist
confer
therefor
minor
compon
mutant
spectra
quasispeci
maintain
memori
record
previou
evolutionari
histori
becom
domin
similar
select
pressur
origin
reintroduc
case
analys
shown
presenc
minor
memori
genom
sampl
origin
major
mutant
spectrum
sampl
respect
experiment
result
strongli
suggest
particip
memori
genom
success
domin
differ
mutant
distribut
presenc
memori
genom
harbour
constel
mutat
associ
resist
antiretrovir
inhibitor
differ
mutat
present
domin
genom
confer
viru
select
advantag
respond
rapidli
whenev
chang
treatment
implement
probabl
inhibitorbas
environment
fluctuat
favour
identif
two
kind
memori
genom
case
studi
howev
must
consid
environment
fluctuat
either
intern
due
physiolog
alter
extern
treatment
interrupt
may
also
favour
memori
genom
select
reservoir
gain
domin
replic
pool
virus
mathemat
model
develop
contempl
replic
nonrepl
reservoir
memori
base
theori
quasispeci
consid
threecompon
model
third
compon
come
latent
reservoir
activ
biolog
stimulu
opportunist
pathogen
distinct
contribut
memori
sourc
obviou
irrupt
third
nonrepl
compon
latent
reservoir
may
resembl
rise
replic
minor
genom
particip
multicompon
dynam
circul
quasispeci
numer
solut
time
evolut
system
equat
involv
three
compon
shown
replic
nonrepl
memori
produc
minor
genom
steadyst
first
approxim
due
small
valu
compar
k
j
proport
respect
figur
nevertheless
mathemat
model
approxim
without
dynam
mechan
k
j
could
relev
quasispeci
dynam
vivo
despit
fact
reservoir
memori
immedi
consequ
replic
dynam
retrovirus
must
point
implic
may
extend
rna
virus
whenev
multipl
replic
site
occur
within
organ
rna
virus
appear
highli
monotrop
human
hepat
virus
replic
mainli
hepatocyt
review
viral
system
see
domingo
howev
rna
virus
sever
picornavirus
flavivirus
coronavirus
etc
may
target
differ
organ
cell
subset
provid
complex
mosaic
quasispeci
distribut
model
appli
whenev
slower
replic
mutant
distribut
increas
replic
rate
exampl
result
immuneescap
local
physiolog
alter
increas
permiss
viral
replic
enter
competit
mutant
distribut
addit
studi
quasispeci
memori
nonretrovir
rna
virus
vivo
need
applic
model
present
assess
result
emphas
mutant
spectra
evolv
quasispeci
may
represent
mutant
distribut
gener
result
mutat
pressur
rel
fit
mutant
gener
may
also
includ
historydepend
substructur
composit
genom
practic
point
view
encourag
develop
analyt
procedur
determin
one
time
domin
genom
sequenc
also
minor
genom
may
reflect
evolutionari
histori
viru
may
provid
basi
rapid
adapt
microarraybas
technolog
offer
potenti
detect
minor
sequenc
rang
genom
popul
case
predict
valu
regard
treatment
efficaci
sampl
obtain
three
patient
undergo
highli
activ
antiretrovir
therapi
haart
hospit
carlo
iii
madrid
spain
infect
b
subtyp
strain
link
epidemiolog
patient
case
intraven
drug
user
born
becam
seroposit
period
patient
case
born
infect
homosexu
intercours
undetermin
time
patient
case
haemophiliac
man
born
infect
age
receiv
contamin
blood
product
sequenti
retrospect
sampl
three
patient
collect
plasma
viremia
quantifi
use
quantiplex
bdna
assay
bayer
barcelona
spain
detect
limit
hivrna
copiesml
version
respect
count
measur
flow
cytometri
coulter
madrid
spain
rna
extract
revers
transcript
pcr
amplif
nucleotid
sequenc
viral
rna
extract
plasma
sampl
silicabas
method
rna
reversetranscrib
amv
rt
promega
madison
wi
use
either
primer
revers
cttactaacttct
residu
correspond
posit
genom
pol
gene
primer
revers
agt
residu
correspond
posit
env
gene
appropri
provir
dna
extract
peripher
blood
mononuclear
cell
pbmc
lysi
nonion
deterg
tween
proteinas
k
nest
pcr
use
amplifi
two
fragment
genom
region
bp
pol
gene
includ
bp
preced
start
prcode
region
entir
prcode
region
first
codon
rt
b
region
bp
env
gene
includ
hypervari
loop
protein
extern
primer
use
amplifi
pol
region
forward
cagccccaccagaaga
posit
inner
primer
forward
posit
revers
agttcata
posit
amplif
env
region
carri
extern
primer
forward
cacagta
posit
inner
one
forward
posit
revers
ttacagtaga
posit
pcr
reaction
perform
use
highfidel
thermost
pfu
dna
polymeras
promega
madison
wi
accord
manufactur
protocol
consensu
nucleotid
sequenc
determin
strand
purifi
pcramplifi
dna
use
abi
prism
bigdy
termin
cycl
sequenc
kit
appli
biosystem
foster
citi
ca
sequenc
pol
fragment
obtain
forward
primer
posit
revers
one
posit
sequenc
env
region
obtain
primer
sequenc
align
assembl
bp
pol
bp
env
contig
perform
mean
lasergen
packag
dnastar
inc
madison
wi
nucleotid
sequenc
deposit
genbank
databas
access
number
nucleotid
sequenc
molecular
clone
six
sequenti
sampl
extract
case
see
tabl
describ
elsewher
genbank
access
number
sequenc
multipl
align
consensu
sequenc
molecular
clone
carri
program
clustal
w
use
genbank
access
number
refer
sequenc
evolutionari
distanc
estim
program
dnadist
phylip
packag
use
kimura
correct
method
weigh
transit
transvers
tree
topolog
infer
neighborjoin
method
nj
use
program
neighbor
phylip
topolog
tree
also
determin
differ
distancebas
cladist
method
unweight
pair
group
method
arithmet
mean
upgma
use
neighbor
phylip
altern
procedur
use
measur
genet
related
among
sampl
maximum
parsimoni
mp
method
program
dnapar
phylip
packag
use
construct
tree
topolog
requir
least
number
sequenc
chang
one
node
anoth
bootstrap
resampl
data
set
multipl
align
use
test
statist
robust
tree
obtain
nj
upgma
mp
method
maximum
likelihood
ml
tree
gener
program
puzzl
use
tamuranei
substitut
model
gamma
distribut
rate
eight
paramet
heterogen
model
model
appli
phylogenet
analysi
human
retrovirus
numer
method
code
written
c
develop
solv
numer
system
differenti
equat
mathemat
model
incorpor
rung
kutta
solver
second
order
run
linux
workstat
